Sugarlogix is a biotechnology startup founded in 2016 with the slogan "Crafting prebiotic sugars to boost gut health and enhance your immune system naturally." The company is focused on developing prebiotic sugars found in human breast milk to offer functional benefits for gut health. This innovation aims to restore balance to the gut microbiome, thereby boosting the immune system and reducing inflammation. With its presence in the Baby & Children's Product, Biotechnology, Consumer Goods, Food and Beverage, and Health Care industries, Sugarlogix has garnered attention from investors. Notably, the company received a Convertible Note investment on 21 June 2021 from SOSV, showcasing investor confidence in the potential of its product.
No recent news or press coverage available for Sugarlogix.